In furtherance of the communication dated today, December 8, 2022 regarding USFDA Import Alert at Halol facility, Sun Pharmaceutical Industries has informed that it enclosed share additional details on the same in the form of Q&A, as attached.
The above information is a part of company’s filings submitted to BSE.